1. Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine;al-Harbi;Cancer Chemotherapy and Pharmacology,1992
2. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury;Ambrosio;Circulation,1987
3. Deferoxamine inhibition of human neuroblastoma viability and proliferation;Becton;Cancer Research,1988
4. Antineuroblastoma activity of desferoxamine in human cell lines;Blatt;Cancer Research,1987
5. Mechanism of antineuroblastoma activity of deferoxamine in vitro;Blatt;Journal of Laboratory and Clinical Medicine,1988